<DOC>
	<DOCNO>NCT00439543</DOCNO>
	<brief_summary>Idiopathic pulmonary fibrosis ( IPF ) chronic progressive fibrosing lung disease unknown cause . There effective therapy yet disease mean survival report 3 year diagnosis . Because stiff fibrosis lung , pulmonary hypertension late complication IPF development herald poor outcome patient . For primary pulmonary hypertension , recently effective drug available . However , study efficacy drug patient pulmonary hypertension secondary pulmnary fibrosis , aim trial study safty efficacy `` Iloprost , '' one safe effective drug primary pulmonary hypertension .</brief_summary>
	<brief_title>Trial Iloprost Pulmonary Hypertension Secondary Pulmonary Fibrosis</brief_title>
	<detailed_description>- Prospective open label observational study - Subjects : About 15 patient secondary pulmonary hypertension due IPF pulmonary fibrosis associate collagen vascular disease . - Method : 3 month trial inhale iloprost . Check safty measure pulmonary arterial pressure right heart catheterization , exercise capacity 6 minute walk test , echocardiography , quality life questionnaires trial .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Iloprost</mesh_term>
	<criteria>Diagnosis idiopathic pulmonary fibrosis fibrotic NSIP accord American Thoracic Society European Respiratory Society guideline biopsy diagnosis pulmonary fibrosis associate connective tissue disease . Mean pulmonary artery pressure 30mmHg . NYHA functional class II IV Suffering lung disease pulmonary fibrosis ( COPD , Pulmonary Thromboendarterectomy ) . Administration prostanoids , bosentan , beta blocker phosphodiesterase5 inhibitor . Dosage adjustment calcium channel blocker within 6 week . Resting pulmonary capillary wedge pressure 15mmHg . Bleeding tendency . Bilirubin level 3mg/dl creatinine clearance level 30ml/min . Unstable angina pectoris , myocardial infarction severe arrhythmia within 6 month . Cerebrovascular accident within 6 month . Present lung infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>Pulmonary fibrosis</keyword>
	<keyword>pulmonary hypertension</keyword>
	<keyword>Iloprost</keyword>
	<keyword>Efficacy</keyword>
</DOC>